NERM
IDXX icon

New England Research & Management’s Idexx Laboratories IDXX Stock Holding History

New England Research & Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Sell
555
-3,245
-85% -$1.82M 0.11% 123
2026
Q1 		$2.14M Buy
3,800
+2,600
+217% +$1.67M 0.9% 38
2025
Q4 		$812K Buy
+1,200
New +$817K 0.36% 79
2025
Q3 		– Sell
-445
Closed -$239K – 160
2025
Q2 		$239K Sell
445
-400
-47% -$191K 0.11% 140
2025
Q1 		$355K Sell
845
-1,250
-60% -$543K 0.18% 120
2024
Q4 		$866K Buy
2,095
+715
+52% +$314K 0.44% 74
2024
Q3 		$697K Buy
1,380
+100
+8% +$48.6K 0.33% 92
2024
Q2 		$624K Sell
1,280
-75
-6% -$37.7K 0.3% 105
2024
Q1 		$732K Sell
1,355
-425
-24% -$232K 0.36% 95
2023
Q4 		$988K Buy
1,780
+305
+21% +$143K 0.52% 66
2023
Q3 		$645K Buy
+1,475
New +$736K 0.37% 90
2023
Q1 		– Sell
-1,075
Closed -$439K – 159
2022
Q4 		$439K Sell
1,075
-1,425
-57% -$553K 0.25% 116
2022
Q3 		$815K Buy
+2,500
New +$918K 0.51% 71
2022
Q2 		– Sell
-575
Closed -$315K – 166
2022
Q1 		$315K Hold
575
– – 0.16% 131
2021
Q4 		$379K Hold
575
– – 0.18% 129
2021
Q3 		$358K Hold
575
– – 0.19% 130
2021
Q2 		$363K Hold
575
– – 0.19% 131
2021
Q1 		$281K Sell
575
-25
-4% -$12.5K 0.15% 144
2020
Q4 		$300K Hold
600
– – 0.19% 135
2020
Q3 		$236K Sell
600
-450
-43% -$166K 0.17% 126
2020
Q2 		$347K Hold
1,050
– – 0.25% 115
2020
Q1 		$254K Buy
+1,050
New +$274K 0.22% 117
2019
Q1 		– Sell
-1,725
Closed -$321K – 172
2018
Q4 		$321K Buy
+1,725
New +$354K 0.25% 117
2016
Q1 		– Sell
-4,050
Closed -$295K – 168
2015
Q4 		$295K Buy
+4,050
New +$289K 0.26% 126
2014
Q4 		– Sell
-9,200
Closed -$542K – 180
2014
Q3 		$542K Buy
+9,200
New +$582K 0.47% 92

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

New England Research & Management's IDXX Position: Q2 2026 in Review

New England Research & Management reduced its Idexx Laboratories (IDXX) stake by 85% in Q2 2026, selling an estimated $1.82M and leaving 555 shares worth $292K. The position accounts for 0.11% of the portfolio, ranked #123.

New England Research & Management first reported a position in IDXX in Q3 2014 and has held it in 25 quarters since. The position peaked at $2.14M in Q1 2026. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • New England Research & Management held 555 shares of Idexx Laboratories worth $292K as of Q2 2026.
  • New England Research & Management sold 3,245 Idexx Laboratories shares in Q2 2026, an estimated $1.82M.
  • Idexx Laboratories made up 0.11% of New England Research & Management's portfolio in Q2 2026, its #123 holding.
  • New England Research & Management first reported a position in Idexx Laboratories in Q3 2014 and has held it in 25 quarters since.
  • New England Research & Management's Idexx Laboratories position peaked at $2.14M in Q1 2026.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.